We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-0.89%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$849M
AUM Growth
+$64.3M
Cap. Flow
+$67.4M
Cap. Flow %
7.94%
Top 10 Hldgs %
45.35%
Holding
87
New
28
Increased
23
Reduced
11
Closed
22

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$19.2M
2
INCY icon
Incyte
INCY
+$18.5M
3
ASRT
Assertio
ASRT
+$17.4M
4
DKS icon
Dick's Sporting Goods
DKS
+$15.9M
5
CPB icon
Campbell Soup
CPB
+$15M

Top Sells

Rank Stock Value
1
HAIN icon
Hain Celestial
HAIN
+$27.8M
2
SGI
Somnigroup International
SGI
+$20.7M
3
PRKS icon
United Parks & Resorts
PRKS
+$13.7M
4
GCI
Gannett Co., Inc
GCI
+$13.4M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$12.2M

Sector Composition

Rank Sector Weight
1 Healthcare 30.77%
2 Consumer Discretionary 18.98%
3 Consumer Staples 9.7%
4 Industrials 3.8%
5 Technology 0.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBBP
26
DELISTED
Strongbridge Biopharma plc.
SBBP
$11.7M 1.38%
1,694,600
+2,600
+0.2% +$17.9K
SAM icon
27
Boston Beer
SAM
$1.86B
$10.9M 1.29%
+70,000
New +$10.2M
PCRX icon
28
Pacira BioSciences
PCRX
$1.01B
$10.8M 1.27%
+288,000
New +$11.6M
TPR icon
29
Tapestry
TPR
$28.6B
$10.5M 1.23%
+260,000
New +$11.5M
PII icon
30
Polaris
PII
$4.16B
$10.5M 1.23%
100,000
-116,000
-54% -$11M
HBI
31
DELISTED
Hanesbrands
HBI
$10.4M 1.23%
424,000
-176,000
-29% -$4.22M
IRBT
32
DELISTED
iRobot
IRBT
$10.2M 1.2%
+132,000
New +$12.1M
HZNP
33
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$10.1M 1.19%
800,000
-20,000
-2% -$254K
ANF icon
34
Abercrombie & Fitch
ANF
$4.23B
$10.1M 1.19%
700,000
-200,000
-22% -$2.29M
MDGL icon
35
Madrigal Pharmaceuticals
MDGL
$12.8B
$9.54M 1.12%
212,000
-70,000
-25% -$1.31M
ISEE
36
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$9.49M 1.12%
3,364,000
+964,000
+40% +$2.6M
BJRI icon
37
BJ's Restaurants
BJRI
$1.42B
$9.13M 1.08%
300,000
+192,000
+178% +$6.22M
ALIM
38
DELISTED
Alimera Sciences
ALIM
$8.46M 1%
417,600
+24,267
+6% +$519K
FTD
39
DELISTED
FTD Companies, Inc. Common Stock
FTD
$8.14M 0.96%
624,000
+96,000
+18% +$1.53M
TTSH
40
DELISTED
Tile Shop Holdings
TTSH
$8.03M 0.95%
+632,000
New +$9.88M
ZGNX
41
PUT
DELISTED
Zogenix, Inc.
ZGNX
$7.01M 0.83%
+200,000
New +$2.71M
ETSY icon
42
Etsy
ETSY
$7.98B
$6.75M 0.8%
+400,000
New +$6.31M
PRKS icon
43
CALL
United Parks & Resorts
PRKS
$2.13B
$6.5M 0.77%
+500,000
New +$6.84M
PAG icon
44
Penske Automotive Group
PAG
$13.3B
$5.9M 0.69%
+124,000
New +$5.36M
BETR
45
DELISTED
Amplify Snack Brands, Inc.
BETR
$5.79M 0.68%
+816,000
New +$6.71M
NTRI
46
DELISTED
NutriSystem, Inc.
NTRI
$5.59M 0.66%
100,000
– –
BLUE
47
DELISTED
bluebird bio
BLUE
$5.22M 0.61%
2,934
+772
+36% +$1.08M
ENTA icon
48
Enanta Pharmaceuticals
ENTA
$400M
$5.05M 0.6%
108,000
-156,000
-59% -$6.27M
ACHN
49
DELISTED
Achillion Pharmaceuticals
ACHN
$4.58M 0.54%
+1,020,000
New +$4.53M
SFM icon
50
Sprouts Farmers Market
SFM
$7.13B
$4.43M 0.52%
+236,000
New +$5.22M
1
2
3 4

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q3 2017 Portfolio in Review

As of Q3 2017, Armistice Capital held 87 positions worth $849M, up 8.2% from $785M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Armistice Capital deployed $67.4M of net new capital in Q3 2017, opening 28 new positions and adding to 23 existing holdings. Its largest new stake was United Therapeutics: 150,000 shares worth $17.6M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Momenta Pharmaceuticals, Inc., an estimated $11.5M trimmed.

  • Armistice Capital's largest Q3 2017 buy was United Therapeutics: 150,000 shares worth $17.6M.
  • Armistice Capital added most to Assertio in Q3 2017, an estimated $17.4M increase.
  • Armistice Capital's biggest Q3 2017 reduction was Momenta Pharmaceuticals, Inc., cutting an estimated $11.5M.
  • Armistice Capital fully exited Hain Celestial in Q3 2017, selling an estimated $27.8M.
  • Armistice Capital's ten largest holdings make up 45% of its $849M portfolio in Q3 2017.
  • Armistice Capital opened 28 new positions and closed 22 in Q3 2017.
  • Armistice Capital's portfolio value rose 8.2% quarter-over-quarter to $849M.

Based on Armistice Capital's 13F filing for Q3 2017, filed 14 Nov 2017.